BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10451487)

  • 1. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma.
    Le Bail B; Faouzi S; Boussarie L; Guirouilh J; Blanc JF; Carles J; Bioulac-Sage P; Balabaud C; Rosenbaum J
    J Pathol; 1999 Sep; 189(1):46-52. PubMed ID: 10451487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.
    Blazejewski S; Le Bail B; Boussarie L; Blanc JF; Malaval L; Okubo K; Saric J; Bioulac-Sage P; Rosenbaum J
    Am J Pathol; 1997 Sep; 151(3):651-7. PubMed ID: 9284812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
    J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
    Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
    Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
    Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
    Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
    Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
    Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
    Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
    Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
    Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
    Dai D; Zhai W; Zhu T; Zhu H; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas.
    Okazaki I; Wada N; Nakano M; Saito A; Takasaki K; Doi M; Kameyama K; Otani Y; Kubochi K; Niioka M; Watanabe T; Maruyama K
    Hepatology; 1997 Mar; 25(3):580-4. PubMed ID: 9049202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
    Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma.
    Ashida K; Nakatsukasa H; Higashi T; Ohguchi S; Hino N; Nouso K; Urabe Y; Yoshida K; Kinugasa N; Tsuji T
    Am J Pathol; 1996 Dec; 149(6):1803-11. PubMed ID: 8952517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
    Int J Oncol; 2000 Jul; 17(1):83-8. PubMed ID: 10853022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.